New “pseudo cell” formulation could revolutionize treatment of vitreoretinal diseases

Researchers from the Institute of Process Engineering (IPE) of the Chinese Academy of Sciences and Beijing Chaoyang Hospital have developed a new “pseudo cell” formulation based on self-healing microcapsule-loading exosomes to treat diverse vitreoretinal diseases.

A Mystery Illness Has Killed Dozens in Congo. WHO Experts Are Now Investigating.

KINSHASA, Congo — The World Health Organization (WHO) said Friday it was deploying experts to investigate a mystery flu-like illness that has killed dozens of

December 7, 2024

J&J, Protagonist reveal two Phase 3 wins for oral IL-23 drug that’s expected to be a blockbuster

Johnson & Johnson and Protagonist Therapeutics announced two Phase 3 successes for their oral IL-23 drug, showcasing the first results out of an expansive pivotal

November 20, 2024

Gene Therapy May Be a Game Changer for Transfusion-Dependent Thalassemia

The development and approval of gene therapies has been a potential game changer for patients with beta-thalassaemia who have been dependent on regular red blood

February 8, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.